The oncometabolite 2-hydroxyglutarate activates the mTOR signalling pathway

The oncometabolite 2-hydroxyglutarate activates the mTOR signalling pathway

The identification of cancer-associated mutations in the tricarboxylic acid (TCA) cycle enzymes isocitrate dehydrogenases 1 and 2 (IDH1/2) highlights the prevailing notion that aberrant metabolic function can contribute to carcinogenesis. IDH1/2 normally catalyse the oxidative decarboxylation of iso...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς:	Carbonneau, M, M Gagné, L, Lalonde, M, Germain, M, Motorina, A, Guiot, M, Secco, B, Vincent, E, Tumber, A, Hulea, L, Bergeman, J, Oppermann, U, Jones, R, Laplante, M, Topisirovic, I, Petrecca, K, Huot, M, Mallette, F
Μορφή:	Journal article
Γλώσσα:	English
Έκδοση:	Springer Nature 2016

Παρόμοια τεκμήρια

The oncometabolite 2-hydroxyglutarate inhibits histone lysine demethylases.
ανά: Chowdhury, R, κ.ά.
Έκδοση: (2011)

The oncometabolite 2-hydroxyglutarate inhibits histone lysine demethylases
ανά: Chowdhury, R, κ.ά.
Έκδοση: (2011)

The oncometabolite 2-hydroxyglutarate inhibits histone lysine demethylases
ανά: Chowdhury, R, κ.ά.
Έκδοση: (2011)

Human Phosphoglycerate Dehydrogenase Produces the Oncometabolite d-2-Hydroxyglutarate
ανά: Teng, Xin, κ.ά.
Έκδοση: (2016)

Oncometabolite 2-hydroxyglutarate regulates anti-tumor immunity
ανά: Mengyuan Cai, κ.ά.
Έκδοση: (2024-01-01)

Potent immunosuppressive effects of the oncometabolite R-2-hydroxyglutarate
ανά: Lorenzo Galluzzi, κ.ά.
Έκδοση: (2018-12-01)

The Enzymology of 2-Hydroxyglutarate, 2-Hydroxyglutaramate and 2-Hydroxysuccinamate and Their Relationship to Oncometabolites
ανά: Vivek A. Hariharan, κ.ά.
Έκδοση: (2017-03-01)

Focused screening identifies different sensitivities of human TET oxygenases to the oncometabolite 2-hydroxyglutarate
ανά: Belle, R, κ.ά.
Έκδοση: (2024)

Registered report: Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of α-ketoglutarate-dependent dioxygenases
ανά: Brad Evans, κ.ά.
Έκδοση: (2015-07-01)

Oncometabolites D- and L-2-hydroxyglutarate Inhibit the AlkB Family DNA Repair Enzymes under Physiological Conditions
ανά: Chen, Fangyi, κ.ά.
Έκδοση: (2018)

Oncometabolite D-2-hydroxyglutarate—dependent metabolic reprogramming induces skeletal muscle atrophy during cancer cachexia
ανά: Xinting Zhu, κ.ά.
Έκδοση: (2023-09-01)

mTOR Signaling in Growth Control and Disease
ανά: Laplante, Mathieu, κ.ά.
Έκδοση: (2014)

Intracerebral Distribution of the Oncometabolite D-2-Hydroxyglutarate in Mice Bearing Mutant Isocitrate Dehydrogenase Brain Tumors: Implications for Tumorigenesis
ανά: Amanda Pickard, κ.ά.
Έκδοση: (2016-10-01)

Renal oncometabolite L-2-hydroxyglutarate imposes a block in kidney tubulogenesis: Evidence for an epigenetic basis for the L-2HG-induced impairment of differentiation
ανά: Mary Taub, κ.ά.
Έκδοση: (2022-09-01)

Oncometabolite D-2-Hydroxyglutarate enhances gene silencing through inhibition of specific H3K36 histone demethylases
ανά: Ryan Janke, κ.ά.
Έκδοση: (2017-03-01)

The IDH1 Mutation-Induced Oncometabolite, 2-Hydroxyglutarate, May Affect DNA Methylation and Expression of PD-L1 in Gliomas
ανά: Luyan Mu, κ.ά.
Έκδοση: (2018-03-01)

An emerging role of mTOR in lipid biosynthesis
ανά: Laplante, Mathieu, κ.ά.
Έκδοση: (2012)

Accumulation of oncometabolite D-2-Hydroxyglutarate by SLC25A1 inhibition: A metabolic strategy for induction of HR-ness and radiosensitivity
ανά: Kexu Xiang, κ.ά.
Έκδοση: (2022-07-01)

The emerging role of fumarate as an oncometabolite.
ανά: Yang, M, κ.ά.
Έκδοση: (2012)

Treatment with a Small Molecule Mutant IDH1 Inhibitor Suppresses Tumorigenic Activity and Decreases Production of the Oncometabolite 2-Hydroxyglutarate in Human Chondrosarcoma Cells.
ανά: Luyuan Li, κ.ά.
Έκδοση: (2015-01-01)

Oncometabolites: linking altered metabolism with cancer.
ανά: Yang, M, κ.ά.
Έκδοση: (2013)

Hydroxyglutaric Acidemia
ανά: J Gordon Millichap
Έκδοση: (1992-09-01)

The Emerging Role of LPA as an Oncometabolite
ανά: Theodoros Karalis, κ.ά.
Έκδοση: (2024-04-01)

The emerging role of fumarate as an oncometabolite
ανά: Ming eYang, κ.ά.
Έκδοση: (2012-07-01)

Targeting mTOR in Acute Lymphoblastic Leukemia
ανά: Carolina Simioni, κ.ά.
Έκδοση: (2019-02-01)

Oncometabolites: A new insight for oncology
ανά: Fatemeh Khatami, κ.ά.
Έκδοση: (2019-09-01)

Autism and Hydroxyglutaric Aciduria
ανά: J Gordon Millichap
Έκδοση: (2008-04-01)

The Roles of 2-Hydroxyglutarate
ανά: Xin Du, κ.ά.
Έκδοση: (2021-03-01)

DEPTOR Is an mTOR Inhibitor Frequently Overexpressed in Multiple Myeloma Cells and Required for Their Survival
ανά: Peterson, Timothy R., κ.ά.
Έκδοση: (2015)

AAA + ATPase Thorase inhibits mTOR signaling through the disassembly of the mTOR complex 1
ανά: George K. E. Umanah, κ.ά.
Έκδοση: (2022-08-01)

Dietary protein sources differentially affect microbiota, mTOR activity and transcription of mTOR signaling pathways in the small intestine.
ανά: Soumya K Kar, κ.ά.
Έκδοση: (2017-01-01)

mTOR at the nexus of nutrition, growth, ageing and disease
ανά: Liu, Grace Y, κ.ά.
Έκδοση: (2021)

MTOR modulation induces selective perturbations in histone methylation which influence the anti-proliferative effects of mTOR inhibitors
ανά: Kim, HaEun, κ.ά.
Έκδοση: (2024)

MTOR modulation induces selective perturbations in histone methylation which influence the anti-proliferative effects of mTOR inhibitors
ανά: HaEun Kim, κ.ά.
Έκδοση: (2024-03-01)

Escaping mTOR inhibition for cancer therapy: Tumor suppressor functions of mTOR
ανά: Victor H. Villar, κ.ά.
Έκδοση: (2017-05-01)

mTOR at the Transmitting and Receiving Ends in Tumor Immunity
ανά: Yakir Guri, κ.ά.
Έκδοση: (2018-03-01)

Oncometabolite induced primary cilia loss in pheochromocytoma
ανά: O'Toole, SM, κ.ά.
Έκδοση: (2019)

mTOR, autophagy and reprogramming
ανά: Bor Luen eTang
Έκδοση: (2014-01-01)

A Central Role for mTOR in Lipid Homeostasis
ανά: Lamming, Dudley W., κ.ά.
Έκδοση: (2016)

The role of the mTor pathway for the development of the mouse thymic epithelium and function
ανά: Berkemeier, C, κ.ά.
Έκδοση: (2010)